Jack Slevin
Stock Analyst at Jefferies
(2.63)
# 2,502
Out of 5,182 analysts
5
Total ratings
75%
Success rate
17.91%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jack Slevin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASTH Astrana Health | Maintains: Buy | $44 → $37 | $34.01 | +8.79% | 1 | Nov 25, 2025 | |
| AGL agilon health | Maintains: Hold | $60 → $28 | $25.32 | +8.61% | 1 | Aug 15, 2025 | |
| MD Pediatrix Medical Group | Maintains: Buy | $14 → $18 | $23.39 | -23.04% | 2 | Nov 5, 2024 | |
| TOI The Oncology Institute | Assumes: Buy | $2.5 | $3.33 | -24.92% | 1 | Feb 26, 2024 |
Astrana Health
Nov 25, 2025
Maintains: Buy
Price Target: $44 → $37
Current: $34.01
Upside: +8.79%
agilon health
Aug 15, 2025
Maintains: Hold
Price Target: $60 → $28
Current: $25.32
Upside: +8.61%
Pediatrix Medical Group
Nov 5, 2024
Maintains: Buy
Price Target: $14 → $18
Current: $23.39
Upside: -23.04%
The Oncology Institute
Feb 26, 2024
Assumes: Buy
Price Target: $2.5
Current: $3.33
Upside: -24.92%